Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome

Condition:   Sturge-Weber Syndrome Intervention:   Drug: Sirolimus Sponsors:   Anne Comi, MD;   Children's Hospital Medical Center, Cincinnati;   Pfizer;   National Institutes of Health (NIH);   Faneca 66 Foundation;   National Institute of Neurological Disorders and Stroke (NINDS) Recruiting - verified February 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials